Exhibit 32.2
                                  Certification
                       Pursuant to 18 U.S.C. Section 1350,
                                   As Adopted
                         Pursuant to Section 906 of the
                                   Sarbanes -
                                Oxley Act of 2002

In connection with the quarterly report (the "Report") of China
Biopharmaceuticals Holdings, Inc. (the "Company") on Form 10-Q for the quarter
ended March 31, 2008 as filed with the Securities and Exchange Commission on the
date hereof, I, Zhang Jian, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act
of 2002, that to my knowledge:

     i. the Report fully complies with the requirements of Section 13(a)or 15(d)
     of the Securities Exchange Act of 1934; and

     ii. the information contained in the Report fairly presents, in all
     material respects, the financial condition and results of operations of the
     Company.

A signed original of this written statement has been provided to the Company and
will be retained by the Company and will be furnished to the Securities Exchange
Commission or its staff upon request.

/s/ Zhang Jian
- --------------

Zhang Jian
Chairwoman and Chief Financial Officer
May 15, 2008

This Certification of Chief Financial Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 is not "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934 but is instead furnished as provided by
applicable rules of the Securities Exchange Commission.